BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20836556)

  • 1. Synthesis and selective anticancer activity of organochalcogen based redox catalysts.
    Doering M; Ba LA; Lilienthal N; Nicco C; Scherer C; Abbas M; Zada AA; Coriat R; Burkholz T; Wessjohann L; Diederich M; Batteux F; Herling M; Jacob C
    J Med Chem; 2010 Oct; 53(19):6954-63. PubMed ID: 20836556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium- and tellurium-containing multifunctional redox agents as biochemical redox modulators with selective cytotoxicity.
    Jamier V; Ba LA; Jacob C
    Chemistry; 2010 Sep; 16(36):10920-8. PubMed ID: 20677196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional redox catalysts as selective enhancers of oxidative stress.
    Fry FH; Holme AL; Giles NM; Giles GI; Collins C; Holt K; Pariagh S; Gelbrich T; Hursthouse MB; Gutowski NJ; Jacob C
    Org Biomol Chem; 2005 Jul; 3(14):2579-87. PubMed ID: 15999190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
    Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
    Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel peptidomimetic compounds containing redox active chalcogens and quinones as potential anticancer agents.
    Shaaban S; Diestel R; Hinkelmann B; Muthukumar Y; Verma RP; Sasse F; Jacob C
    Eur J Med Chem; 2012 Dec; 58():192-205. PubMed ID: 23124216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-synthesis and anti-tumor activity of 5,8-O-dimethyl acylshikonin derivatives.
    Zhou W; Peng Y; Li SS
    Eur J Med Chem; 2010 Dec; 45(12):6005-11. PubMed ID: 20970893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on quinones. Part 41: synthesis and cytotoxicity of isoquinoline-containing polycyclic quinones.
    Valderrama JA; González MF; Pessoa-Mahana D; Tapia RA; Fillion H; Pautet F; Rodriguez JA; Theoduloz C; Schmeda-Hirschmann G
    Bioorg Med Chem; 2006 Jul; 14(14):5003-11. PubMed ID: 16563773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines.
    Benites J; Valderrama JA; Rivera F; Rojo L; Campos N; Pedro M; José Nascimento MS
    Bioorg Med Chem; 2008 Jan; 16(2):862-8. PubMed ID: 17964791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the disturbed redox equilibrium in chronic lymphocytic leukemia by novel reactive oxygen species-catalytic 'sensor/effector' compounds.
    Lilienthal N; Prinz C; Peer-Zada AA; Doering M; Ba LA; Hallek M; Jacob C; Herling M
    Leuk Lymphoma; 2011 Jul; 52(7):1407-11. PubMed ID: 21476834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semisynthesis and antitumoral activity of 2-acetylfuranonaphthoquinone and other naphthoquinone derivatives from lapachol.
    Eyong KO; Kumar PS; Kuete V; Folefoc GN; Nkengfack EA; Baskaran S
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5387-90. PubMed ID: 18829316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological evaluation of donor-acceptor aminonaphthoquinones as antitumor agents.
    Benites J; Valderrama JA; Bettega K; Pedrosa RC; Calderon PB; Verrax J
    Eur J Med Chem; 2010 Dec; 45(12):6052-7. PubMed ID: 20980080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of some steroidal oximes, lactams, thiolactams and their antitumor activities.
    Krstić NM; Bjelaković MS; Zizak Z; Pavlović MD; Juranić ZD; Pavlović VD
    Steroids; 2007 May; 72(5):406-14. PubMed ID: 17433824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on quinones. Part 46. Synthesis and in vitro antitumor evaluation of aminopyrimidoisoquinolinequinones.
    Vásquez D; Rodríguez JA; Theoduloz C; Calderon PB; Valderrama JA
    Eur J Med Chem; 2010 Nov; 45(11):5234-42. PubMed ID: 20828890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines.
    Mól W; Matyja M; Filip B; Wietrzyk J; Boryczka S
    Bioorg Med Chem; 2008 Sep; 16(17):8136-41. PubMed ID: 18682326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of structurally simplified analogues of aplidinone A, a pro-apoptotic marine thiazinoquinone.
    Aiello A; Fattorusso E; Luciano P; Menna M; Calzado MA; Muñoz E; Bonadies F; Guiso M; Sanasi MF; Cocco G; Nicoletti R
    Bioorg Med Chem; 2010 Jan; 18(2):719-27. PubMed ID: 20031419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of selenazolopyridine derivatives with capability to induce apoptosis in human breast carcinoma MCF-7 cells through scavenge of intracellular ROS.
    Zhou M; Ji S; Wu Z; Li Y; Zheng W; Zhou H; Chen T
    Eur J Med Chem; 2015; 96():92-7. PubMed ID: 25874334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro anticancer activity of 6,7-methylenedioxy (or 5-hydroxy-6-methoxy)-2-(substituted selenophenyl)quinolin-4-one analogs.
    Chen CT; Hsu MH; Cheng YY; Liu CY; Chou LC; Huang LJ; Wu TS; Yang X; Lee KH; Kuo SC
    Eur J Med Chem; 2011 Dec; 46(12):6046-56. PubMed ID: 22030314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes.
    Shanab K; Pongprom N; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6091-5. PubMed ID: 17904839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
    Marx KA; O'Neil P; Hoffman P; Ujwal ML
    J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
    Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
    Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.